Evofem Biosciences, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 51
- Market Cap
- $1M
- Website
- http://www.evofem.com
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
- Conditions
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 1892
- Registration Number
- NCT04553068
- Locations
- 🇺🇸
Matrix Clinical Research, Los Angeles, California, United States
🇺🇸Urgent Care Clinical Trials @City Doc Urgent Care-Inwood, Dallas, Texas, United States
🇺🇸Planned Parenthood Southeastern Pennsylvania, Philadelphia, Pennsylvania, United States
AMP002 Phase III Contraceptive Study
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 1384
- Registration Number
- NCT03243305
- Locations
- 🇺🇸
The Community Research of South Florida 167, Hialeah, Florida, United States
🇺🇸Vital Pharma Research, Inc. 123, Hialeah, Florida, United States
🇺🇸Mesa Obstetricians & Gynecologists 184, Mesa, Arizona, United States
Phase 2B/3 Double-blinded Placebo-controlled
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 860
- Registration Number
- NCT03107377
- Locations
- 🇺🇸
University of Tennessee Medical Center, Knoxville, Tennessee, United States
🇺🇸CityDoc Urgent Care, Dallas, Texas, United States
🇺🇸Planned Parenthood Southeastern Pennsylvania, Philadelphia, Pennsylvania, United States
Duration of Effect of Acidform Gel on Vaginal pH
- Conditions
- Interventions
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT02693418
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸Metro Health Medical Center, Cleveland, Ohio, United States
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02483533
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 793
- Registration Number
- NCT02398188
- Locations
- 🇺🇸
Society Hill Dermatology, Philadelphia, Pennsylvania, United States
🇺🇸Wake Research Associates, Raleigh, North Carolina, United States
🇺🇸Zel Skin & Laser Specialist, LLC, Edina, Minnesota, United States
Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel
- First Posted Date
- 2011-03-01
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Evofem Inc.
- Target Recruit Count
- 3389
- Registration Number
- NCT01306331
- Locations
- 🇺🇸
Wake Research Associates, Raleigh, North Carolina, United States
🇺🇸University of Pennsylvania Medical Center, Reproductive Research Unit, Philadelphia, Pennsylvania, United States
🇺🇸Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States